Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
mycophenolate mofetil inosine-5'-monophosphate dehydrogenase 1 small molecule NA drugbank , DGIDB Lupus Nephritis[MeSHID:D008181]
Hepatitis A[MeSHID:D006506]
Neoplasm Metastasis[MeSHID:D009362]
Dermatitis[MeSHID:D003872]
Off-Label Use[MeSHID:D056687]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Transplanted organ[MeSHID:D019737]
Pemphigus Vulgaris[MeSHID:D010392]
Immune System Diseases[MeSHID:D007154]		 NA approved,investigational inhibitor,inducer
mycophenolate mofetil inosine-5'-monophosphate dehydrogenase 1 small molecule NA drugbank , DGIDB Lupus Nephritis[MeSHID:D008181]
Hepatitis A[MeSHID:D006506]
Neoplasm Metastasis[MeSHID:D009362]
Dermatitis[MeSHID:D003872]
Off-Label Use[MeSHID:D056687]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Middle East Respiratory Syndrome[MeSHID:D018352]		 NA approved,investigational inhibitor,inducer
mycophenolate mofetil inosine-5'-monophosphate dehydrogenase 1 small molecule NA drugbank , DGIDB Lupus Nephritis[MeSHID:D008181]
Hepatitis A[MeSHID:D006506]
Neoplasm Metastasis[MeSHID:D009362]
Dermatitis[MeSHID:D003872]
Off-Label Use[MeSHID:D056687]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Middle East Respiratory Syndrome[MeSHID:D018352]		 1.06 approved,investigational inhibitor,inducer
mycophenolate mofetil inosine-5'-monophosphate dehydrogenase 1 small molecule NA drugbank , DGIDB Lupus Nephritis[MeSHID:D008181]
Hepatitis A[MeSHID:D006506]
Neoplasm Metastasis[MeSHID:D009362]
Dermatitis[MeSHID:D003872]
Off-Label Use[MeSHID:D056687]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Transplanted organ[MeSHID:D019737]
Pemphigus Vulgaris[MeSHID:D010392]
Immune System Diseases[MeSHID:D007154]		 1.06 approved,investigational inhibitor,inducer
mycophenolate mofetil inosine-5'-monophosphate dehydrogenase 2 small molecule Successful target TTD , drugbank , DGIDB Lupus Nephritis[MeSHID:D008181]
Hepatitis A[MeSHID:D006506]
Neoplasm Metastasis[MeSHID:D009362]
Dermatitis[MeSHID:D003872]
Off-Label Use[MeSHID:D056687]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Transplanted organ[MeSHID:D019737]
Pemphigus Vulgaris[MeSHID:D010392]
Immune System Diseases[MeSHID:D007154]		 NA approved,investigational inhibitor
mycophenolate mofetil inosine-5'-monophosphate dehydrogenase 2 small molecule Successful target TTD , drugbank , DGIDB Lupus Nephritis[MeSHID:D008181]
Hepatitis A[MeSHID:D006506]
Neoplasm Metastasis[MeSHID:D009362]
Dermatitis[MeSHID:D003872]
Off-Label Use[MeSHID:D056687]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Middle East Respiratory Syndrome[MeSHID:D018352]		 NA approved,investigational inhibitor
mycophenolate mofetil inosine-5'-monophosphate dehydrogenase 2 small molecule Successful target TTD , drugbank , DGIDB Lupus Nephritis[MeSHID:D008181]
Hepatitis A[MeSHID:D006506]
Neoplasm Metastasis[MeSHID:D009362]
Dermatitis[MeSHID:D003872]
Off-Label Use[MeSHID:D056687]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Middle East Respiratory Syndrome[MeSHID:D018352]		 1.18 approved,investigational inhibitor
mycophenolate mofetil inosine-5'-monophosphate dehydrogenase 2 small molecule Successful target TTD , drugbank , DGIDB Lupus Nephritis[MeSHID:D008181]
Hepatitis A[MeSHID:D006506]
Neoplasm Metastasis[MeSHID:D009362]
Dermatitis[MeSHID:D003872]
Off-Label Use[MeSHID:D056687]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Transplanted organ[MeSHID:D019737]
Pemphigus Vulgaris[MeSHID:D010392]
Immune System Diseases[MeSHID:D007154]		 1.18 approved,investigational inhibitor
mycophenolate mofetil prostaglandin e2 receptor ep2 NA Successful target TTD , DGIDB Lupus Nephritis[MeSHID:D008181]
Hepatitis A[MeSHID:D006506]
Neoplasm Metastasis[MeSHID:D009362]
Dermatitis[MeSHID:D003872]
Off-Label Use[MeSHID:D056687]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Transplanted organ[MeSHID:D019737]
Pemphigus Vulgaris[MeSHID:D010392]
Immune System Diseases[MeSHID:D007154]		 NA approved unknown
mycophenolate mofetil prostaglandin e2 receptor ep2 NA Successful target TTD , DGIDB Lupus Nephritis[MeSHID:D008181]
Hepatitis A[MeSHID:D006506]
Neoplasm Metastasis[MeSHID:D009362]
Dermatitis[MeSHID:D003872]
Off-Label Use[MeSHID:D056687]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Middle East Respiratory Syndrome[MeSHID:D018352]		 NA approved unknown
mycophenolate mofetil 6-pyruvoyl tetrahydrobiopterin synthase small molecule NA drugbank Lupus Nephritis[MeSHID:D008181]
Hepatitis A[MeSHID:D006506]
Neoplasm Metastasis[MeSHID:D009362]
Dermatitis[MeSHID:D003872]
Off-Label Use[MeSHID:D056687]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Transplanted organ[MeSHID:D019737]
Pemphigus Vulgaris[MeSHID:D010392]
Immune System Diseases[MeSHID:D007154]		 NA approved,investigational inhibitor
mycophenolate mofetil 6-pyruvoyl tetrahydrobiopterin synthase small molecule NA drugbank Lupus Nephritis[MeSHID:D008181]
Hepatitis A[MeSHID:D006506]
Neoplasm Metastasis[MeSHID:D009362]
Dermatitis[MeSHID:D003872]
Off-Label Use[MeSHID:D056687]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Middle East Respiratory Syndrome[MeSHID:D018352]		 NA approved,investigational inhibitor
click here to return to the previous page